Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early phase II study of TSU-68 plus docetaxel in advanced/metastatic breast cancer after anthracycline
jRCT2080221143Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of orantinib and docetaxel in breast cancer, sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
orantinibdocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221143.